[ Price : $8.95]
Federal Register Notice: FDA opens a comment period on the topic CDER addresses in a 9/26 public workshop, drug shortages.[ Price : $8.95]
Federal Register Notice: FDA seeks industry organizations interested in helping select representatives for CBER Vaccines advisory ...[ Price : $8.95]
Cubist Pharmaceuticals plans Phase 3 clinical trials of its therapy to treat Clostridium difficile-associated diarrhea.[ Price : $8.95]
FDA and other regulatory and international partners complete a week-long Internet crackdown on producers and distributors of count...[ Price : $8.95]
FDA clears U.S. Army Office of the Surgeon General 510(k)s for two Influenza test kits and their use with Idaho Technology's Joint...[ Price : $8.95]
FDA classifies Pathway Genomics genetic testing kit, blocked last year from OTC sale at Walgreens drug stores, as a Class 1 exempt...[ Price : $8.95]
CDRH chief scientist William Maisel says the Center is planning to release three guidance documents this fall to help improve its ...[ Price : $8.95]
HHS researchers say they found little evidence supporting many off-label uses of atypical antipsychotics.